We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDRX MOVING CLOSER TO CARDURA XL BRAND LAUNCH
ANDRX MOVING CLOSER TO CARDURA XL BRAND LAUNCH
June 29, 2004
The FDA has issued an approvable letter for Pfizer’s new drug application for Cardura XL, a sustained-release formulation of doxazosin mesylate that will be marketed by generic firm Andrx.